[1] KISHI T,HIROOKA Y,SUNAGAWA K.Telmisartan reduces mortality and left ventricular hypertrophy with sympathoinhibition in rats with hypertension and heart failure[J].Am J Hypertens,2013,27(2):260-267.
[2] MISRA K H,DAS M C, RAMANI Y A.Effect of telmisartan on the regression of the left ventricular hypertrophy in the patients of essential hypertension[J].J Clin & Diagn Res Jcdr,2013,7(7):1352-1355.
[3] 黄敏夏.替米沙坦联合硝苯地平缓释片治疗原发性高血压临床分析[J].深圳中西医结合杂志,2016,24(9):121-122.
[4] 邹文淑,王慧玲,王剑峰,等.替米沙坦联合氢氯噻嗪治疗对老年收缩期高血压患者的降压效果及左室肥厚的影响[J].中国老年学杂志,2015,32(12):3283-3284.
[5] 张晓东.通心络胶囊合并替米沙坦对高血压患者血管内皮功能和氧化应激的影响[J].中国循证心血管医学杂志,2016,24(3):364-366.
[6] 陈莉.替米沙坦联合用药治疗老年高血压的临床分析[J].中西医结合心血管病电子杂志,2015,42(36):27-28.
[7] 陈志锋,钟海峰.替米沙坦不同给药时间治疗非杓型社区高血压患者的疗效分析[J].海峡药学,2016,24(4):156-157.
[8] 黄鑫涛,洪华山,李小红,等.替米沙坦对糖尿病高血压大鼠肾内小动脉重构的影响[J].中国循证心血管医学杂志,2015,22(6):821-826.
[9] 葛慷艳,蒋鸽.缬沙坦和替米沙坦治疗老年高血压的疗效[J].江苏医药,2016,34(2):210-211.
[10] GOYAL J,KHAN Z Y,UPADHYAYA P,et al.Comparative study of high dose mono-therapy of amlodipine or telmisartan,and their low dose combination in mild to moderate hypertension[J].J Clin Diagn Res,2014,25(6):90-92.
[11] SADEK S A,RASHED L A,BASSAM A M,et al.Effect of aliskiren,telmisartan and torsemide on cardiac dysfunction in l-nitro arginine methyl ester (l-name) induced hypertension in rats[J].J Adv Res,2015,6(6):967-974.
[12] 顾平,陈岷,李晋奇,等.替米沙坦对比氨氯地平治疗高血压合并糖尿病的疗效和安全性的Meta分析[J].中国生化药物杂志,2016,25(4):203-206.
[13] 张小平,邓艳.替米沙坦不同给药时间治疗非杓型高血压的临床分析[J].湖北科技学院学报:医学版,2016,25(1):17-19.
[14] 郝艳华.替米沙坦不同时间给药治疗非杓型高血压的临床疗效分析[J].中国现代药物应用,2016,32(2):122-123.
[15] KONDO K,TOH R,ISHIDA T,et al.Comparison of telmisartan/amlodipine and telmisartan/hydrochlorothiazide in the treatment of japanese patients with uncontrolled hypertension[J].Blood Press Monit,2016,21(3):171-177. |